Could this describe you?
I am a licensed healthcare professional looking for a trusted resource where my patients can find scientifically-backed research to safely support their psychedelic medicine exploration.
I am an executive coach who believes in the potential of psychedelic medicine. I want my clients to independently explore how these transformative compounds can assist in our work together.
I am an integrative specialist who understands the power psychedelics can bring to the lives of the people for whom I bring care and need a resource that complements my scope of practice.
This describes us.
SetSet offers 3-month Memberships for $147 so women* can access clinician-created Medicine Guides on psilocybin and ketamine. The same clinician, Kendra Bloom (keep scrolling), also created and piloted SetSet's 12-week DIY psilocybin microdosing protocol and our Universal Integration Course that supports every psychedelic medicine at any dose.
*Women is a general term that describes the specific audience that SetSet supports: every.body. navigating life with female hormones. every.body. who feels safest within women-friendly spaces. every.body. experiencing mental health challenges related to the presence and/or absence of female hormones.
Director of Programming
Kendra Bloom
I’m a Master Coach, Licensed Psychotherapist, Nervous System Nerd, Expert Facilitator, and Deep Lover of Transformation.
My work combines modern neurobiology, evolutionary psychology, attachment theory, consciousness science and somatics.
I have 15 years experience as a psychotherapist and nearly five as an integration coach to support psilocybin and ketamine.
For SetSet by Kendra
Support for Psychedelic Medicine
What's Psychedelic Integration?
Psychedelic Integration tools encompass a diverse range of resources and practices designed to support individuals before, during, and after their psychedelic experiences.
These tools aim to facilitate the integration of insights and understanding gained with psychedelic medicine into everyday life, fostering personal growth, emotional healing, and psychological well-being.
Integration tools may include guided meditation and breath work exercises to prepare for the experience, journaling prompts for self-reflection, and weekly alls to process emotions. Additionally, community support networks, online forums, and peer-led integration groups allow individuals to share their experiences and recipe support and connect with others on similar journeys.
The goal of psychedelic integration is to help individuals make sense of their psychedelic experiences, integrate them into their sense of self and worldview, & harness the transformative potential of these experiences for long-term personal development and healing. By offering guidance, support, and practical techniques, these tools empower individuals to navigate the complexities of psychedelic experiences & integrate them into a holistic approach to well-being.
Why Refer Your Patients to SetSet?
Expert
Exclusive access to a community of experts and clinician-backed resources.
Tailored
Female-forward resources to address women's most sought after health needs and symptom relief.
Accessible
Each membership tier is competitively priced so more women can unlock these tools.
Provider Referral Benefits
Referral Commission
Earn 25% commission for Member referrals.
Free Membership
Complimentary Membership for referring Providers.
Ready? Get SetSet. And GO!
Join Us Today!
Embrace the future of healthcare by becoming a SetSet Provider Partner. Enhance your practice, support your patients with the best evidence-based resources, and earn valuable rewards for your referrals.
Together, let's make preventive care and better patient outcomes the standard in healthcare.
Psychedelic FAQs
Research on the long-term mental health effects of psychedelics is still evolving. While some studies suggest potential benefits for conditions such as depression and PTSD, there are concerns about the risk of triggering or exacerbating psychiatric conditions such as psychosis or schizophrenia in susceptible individuals
The legal status of psychedelics varies by country and even by state within countries. Generally, many psychedelics, such as psilocybin and LSD, are classified as Schedule I substances, meaning they are illegal to prescribe, possess, or distribute. Healthcare providers must stay informed about local laws and regulatory changes.
Ensuring patient safety involves conducting thorough medical and psychiatric evaluations, discussing potential risks and benefits, providing harm-reduction strategies, and monitoring patients closely if they choose to use psychedelics. Establishing a clear treatment plan and obtaining informed consent is critical.
Psychedelics can interact with various medications, particularly psychiatric drugs such as SSRIs, MAOIs, antipsychotics, and benzodiazepines. Providers should review patients' medication lists and provide guidance on potential interactions and necessary precautions.
Practitioners who recommend or discuss the use of illegal substances may face legal and professional liability. To mitigate liability risks, it is essential to document patient interactions thoroughly, obtain informed consent, and adhere to local laws and professional guidelines.
When discussing the use of psychedelics, it is vital to obtain informed consent. This process should include a detailed discussion of the potential risks and benefits, legal considerations, and alternative treatment options. Documentation of the informed consent conversation in the patient's medical record is essential.
Microdosing FAQs
Safety guidelines for microdosing typically include starting with very low doses, maintaining a consistent schedule (e.g., dosing every few days), and monitoring for adverse effects. Providers should advise patients to avoid combining microdoses with other psychoactive substances and to seek medical advice if they experience negative symptoms.
The effects of microdosing psychedelics are usually subtle and may last for several hours, depending on the substance and dose. Patients may notice mild improvements in mood, focus, and creativity without experiencing the intense hallucinations associated with higher doses.
Effective dosages for microdosing vary by substance but generally fall between 1/10th and 1/20th of a typical recreational dose. For example, an effective microdose of psilocybin might be around 0.1 to 0.3 grams of dried mushrooms.
Given psilocybin's legal status, safe procurement is challenging. Providers should advise patients to seek information from reputable sources and caution them against purchasing products from unverified or illegal markets. Emphasizing harm reduction practices and legal considerations is crucial. SetSet Support provides members with guidance to procure trusted psilocybin medicine.
